Verona Pharma PLC ADR (VRNA)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

3 MORE LONDON RIVERSIDE LONDON, UNITED KINGDOM SE1 2RE

Verona Pharma PLC. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs.

Data as of 2021-05-08 11:50:04 -0400
Market Cap322.309 Million Shares Outstanding51.818 Million Avg 30-day Volume46.776 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.53149 52-week High/Low15.71 / 3.7 Next Earnings Date2021-08-13 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from VRNA instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 4 -25.0% 1 (0.06%) 1 (0.06%) 0.0%
Funds Holding: 35 29 20.69% 15 (0.9%) 14 (0.87%) 7.14%
13F shares: 35.732 Million 34.077 Million 4.86% 21.693 Million 21.397 Million 1.38%
% Ownership 68.9562 65.7626 4.86% 41.8635 41.2931 1.38%
New Positions: 10 15 -33.33% 3 9 -66.67%
Increased Positions 7 8 -12.5% 3 4 -25.0%
Closed Positions 3 5 -40.0% 1 1 0.0%
Reduced Positions 4 3 33.33% 1 1 0.0%
Total Calls 12.3 Thousand 200 6050.0% 12.1 Thousand
Total Puts 14.8 Thousand 0 14.8 Thousand
PUT/CALL Ratio 1.2 0.0 1.22
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding VRNA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VRNA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

142.2 Thousand total shares from 9 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

EBSWORTH DAVID R

  • Director
684,643 2021-05-04 3

SHAH MAHENDRA

  • Director
73,080 2021-05-04 3

SINHA VIKAS

  • Director
74,440 2021-05-04 3

EDWARDS MARTIN

  • Director
111,064 2021-05-04 3

CUNNINGHAM KENNETH

  • Director
66,584 2021-05-04 3

ULLMAN ANDERS

  • Director
334,856 2021-05-04 3

DESCHAMPS LISA

  • Director
105,320 2021-05-04 3

HAHN MARK W CHIEF FINANCIAL OFFICER

  • Officer
16,921,640 2021-05-03 4

ZACCARDELLI DAVID PRESIDENT AND CEO

  • Officer
  • Director
17,859,160 2021-05-03 4

MAKOWER JOSHUA

  • 10% Owner
40,868,505 2021-01-01 1

SANDELL SCOTT D

  • 10% Owner
40,868,505 2021-01-01 1

BASKETT FOREST

  • 10% Owner
40,868,505 2021-01-01 1

GUPTA RISHI

  • Director
0 2021-01-01 2

SONSINI PETER W.

  • 10% Owner
40,868,505 2021-01-01 1

FLORENCE ANTHONY A. JR.

  • 10% Owner
40,868,505 2021-01-01 1

MAKHZOUMI MOHAMAD

  • 10% Owner
40,868,505 2021-01-01 1

SINCLAIR ANDREW

  • Director
19,660,001 2021-01-01 2

POLL CLAIRE GENERAL COUNSEL

  • Officer
2,886,079 2021-01-01 1

RICKARD KATHLEEN A. CHIEF MEDICAL OFFICER

  • Officer
3,067,152 2021-01-01 1

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VI LLC

  • Director
  • 10% Owner
40,225,392 2021-01-01 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

DESCHAMPS LISA - Director

2021-05-05 17:07:21 -0400 2021-05-04 S 10,680 $0.84 d 105,320 direct yes -0.3205 0.0 1 -0.3205 2

EDWARDS MARTIN - Director

2021-05-05 17:04:23 -0400 2021-05-04 S 12,024 $0.84 d 111,064 direct yes -0.3205 0.0 1 -0.3205 2

SINHA VIKAS - Director

2021-05-05 17:05:53 -0400 2021-05-04 S 10,016 $0.84 d 74,440 direct yes -0.3205 0.0 1 -0.3205 2

ULLMAN ANDERS - Director

2021-05-05 17:07:53 -0400 2021-05-04 S 12,056 $0.84 d 334,856 direct yes -0.3205 0.0 1 -0.3205 2

EBSWORTH DAVID R - Director

2021-05-05 17:04:50 -0400 2021-05-04 S 11,184 $0.84 d 684,643 direct yes -0.3205 0.0 1 -0.3205 2

CUNNINGHAM KENNETH - Director

2021-05-05 17:06:45 -0400 2021-05-04 S 13,112 $0.84 d 66,584 direct yes -0.3205 0.0 1 -0.3205 2

SHAH MAHENDRA - Director

2021-05-05 17:03:35 -0400 2021-05-04 S 10,680 $0.84 d 73,080 direct yes -0.3205 0.0 1 -0.3205 2

ZACCARDELLI DAVID - Director - Officer PRESIDENT AND CEO

2021-05-05 16:06:45 -0400 2021-05-04 S 52,056 $0.81 d 17,859,160 direct yes -0.3205 0.0 1 -0.3205 2

HAHN MARK W - Officer CHIEF FINANCIAL OFFICER

2021-05-05 16:06:06 -0400 2021-05-03 F 2,122,448 $0.89 d 16,932,056 direct -0.3205 0.0 1 -0.3205 2

ZACCARDELLI DAVID - Director - Officer PRESIDENT AND CEO

2021-05-05 16:06:45 -0400 2021-05-03 F 2,139,632 $0.89 d 17,911,216 direct -0.3205 0.0 1 -0.3205 2

HAHN MARK W - Officer CHIEF FINANCIAL OFFICER

2021-05-05 16:06:06 -0400 2021-05-03 S 10,416 $0.87 d 16,921,640 direct yes -0.3205 0.0 1 -0.3205 2

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
VERONA PHARMA PLC - ADR VRNA 2021-05-10 22:15:04 UTC -2.0607 2.1107 70000
VERONA PHARMA PLC - ADR VRNA 2021-05-10 21:45:02 UTC -2.0607 2.1107 70000
VERONA PHARMA PLC - ADR VRNA 2021-05-10 21:15:02 UTC -2.0607 2.1107 70000
VERONA PHARMA PLC - ADR VRNA 2021-05-10 20:45:03 UTC -2.0607 2.1107 70000
VERONA PHARMA PLC - ADR VRNA 2021-05-10 20:15:03 UTC -2.0607 2.1107 70000
VERONA PHARMA PLC - ADR VRNA 2021-05-10 19:45:03 UTC -2.0607 2.1107 70000
VERONA PHARMA PLC - ADR VRNA 2021-05-10 19:15:03 UTC -2.0607 2.1107 70000
VERONA PHARMA PLC - ADR VRNA 2021-05-10 18:45:03 UTC -2.0607 2.1107 70000
VERONA PHARMA PLC - ADR VRNA 2021-05-10 18:15:03 UTC -2.0607 2.1107 70000
VERONA PHARMA PLC - ADR VRNA 2021-05-10 17:45:02 UTC -2.0607 2.1107 70000
VERONA PHARMA PLC - ADR VRNA 2021-05-10 17:15:03 UTC -2.0607 2.1107 70000
VERONA PHARMA PLC - ADR VRNA 2021-05-10 16:45:03 UTC -2.0607 2.1107 70000
VERONA PHARMA PLC - ADR VRNA 2021-05-10 16:15:03 UTC -2.0607 2.1107 70000
VERONA PHARMA PLC - ADR VRNA 2021-05-10 15:45:03 UTC -2.0607 2.1107 50000
VERONA PHARMA PLC - ADR VRNA 2021-05-10 15:15:03 UTC -2.0607 2.1107 50000
VERONA PHARMA PLC - ADR VRNA 2021-05-10 14:45:04 UTC -2.0474 2.0974 50000
VERONA PHARMA PLC - ADR VRNA 2021-05-10 14:15:04 UTC -2.0474 2.0974 50000
VERONA PHARMA PLC - ADR VRNA 2021-05-10 13:45:04 UTC -2.0474 2.0974 50000
VERONA PHARMA PLC - ADR VRNA 2021-05-10 13:15:03 UTC -2.0474 2.0974 50000
VERONA PHARMA PLC - ADR VRNA 2021-05-10 12:45:02 UTC -2.0474 2.0974 50000

Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund VRNA -300.0 shares, $-2508.0 2021-03-31 N-PORT

Short Position History (International Only)

Holder Net Short Position Position Date Origin
Citadel Securities LLC VERONA PHARMA PLC 0.69% 2019-12-27 UK
Citadel Securities LLC VERONA PHARMA PLC 0.59% 2020-01-02 UK

UK Ownership History

Updated daily

Contains transactions from January 1st, 2015 on. This data is

Form Holder Issuer Transaction Date Number of Voting Rights % of Voting Rights
TR-1 Growth Equity Opportunities Fund IV, LLC Growth Equity Opportunities 17, LLC Verona Pharma plc 2020-07-22 40,868,504 9.86%

Elevate your investments